Cargando…

Recurrence of cervical cancer and its resistance to progestin therapy in a mouse model

Studies using K14E6/K14E7 transgenic mice expressing E6 and E7 oncoprotein of human papillomavirus type 16 (HPV16) have demonstrated that estrogen (E(2)) is required for the genesis and growth of cervical cancer. Our prior study using the same mouse model has showed that progestin drug medroxyproges...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehta, Fabiola F, Baik, Seunghan, Chung, Sang-Hyuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356807/ https://www.ncbi.nlm.nih.gov/pubmed/27911853 http://dx.doi.org/10.18632/oncotarget.13676

Ejemplares similares

Medroxyprogesterone Acetate Prevention of Cervical Cancer through Progesterone Receptor in a Human Papillomavirus Transgenic Mouse Model
por: Baik, Seunghan, et al.
Publicado: (2019)

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
por: Liang, Angela L., et al.
Publicado: (2021)

Hypoluteoidism in a dog associated with recurrent mammary fibroadenoma stimulated by progestin therapy
por: Zedda, Maria Teresa, et al.
Publicado: (2017)

The effect of progestin therapy in advanced and recurrent endometrial cancer: A systematic review and meta‐analysis
por: van Weelden, Willem Jan, et al.
Publicado: (2022)

Progestins: Pro-senescence therapy for ovarian cancer?
por: Oesterreich, Steffi, et al.
Publicado: (2013)

Progestin and Nuclear Progestin Receptor Are Essential for Upregulation of Metalloproteinase in Zebrafish Preovulatory Follicles
por: Liu, Dong Teng, et al.
Publicado: (2018)

The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy
por: Cezar, TC, et al.
Publicado: (2018)

Actions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth
por: Kuon, R.-J., et al.
Publicado: (2012)

Modeling the Annual Costs of Postmenopausal Prevention Therapy: Raloxifene, Alendronate, or Estrogen-Progestin Therapy
por: Mullins, C. Daniel, et al.
Publicado: (2003)

Estrogen–progestin replacement therapy: regulatory action needed
por: Pike, Malcolm C, et al.
Publicado: (2002)

Distinct functions and regulation of epithelial progesterone receptor in the mouse cervix, vagina, and uterus
por: Mehta, Fabiola F., et al.
Publicado: (2016)

Progestins and mammary cancer induction.
por: Coezy, E., et al.
Publicado: (1973)

The Progestin Revolution: progestins are arising as the dominant players in the tight interlink between contraceptives and bleeding control
por: Shoupe, Donna
Publicado: (2021)

Gefitinib enhances sensitivity of endometrial cancer cells to progestin therapy via dual-specificity phosphatase 1
por: Yang, Yuan, et al.
Publicado: (2017)

Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway
por: Wang, Yiying, et al.
Publicado: (2016)

The synthetic progestin norgestrel acts to increase LIF levels in the rd10 mouse model of retinitis pigmentosa
por: Byrne, Ashleigh M., et al.
Publicado: (2016)

Α Humanized RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel Therapeutics
por: Kolokotroni, Anthi, et al.
Publicado: (2023)

Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist
por: duPont, Nefertiti Chianti, et al.
Publicado: (2010)

Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins
por: Kulkarni, A., et al.
Publicado: (2023)

The synthetic progestin norgestrel modulates Nrf2 signaling and acts as an antioxidant in a model of retinal degeneration
por: Byrne, Ashleigh M., et al.
Publicado: (2016)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022)

Progestins and the endometrium in patients receiving tamoxifen
Publicado: (1999)

Prenatal Progestin Exposure-Mediated Oxytocin Suppression Contributes to Social Deficits in Mouse Offspring
por: Huang, Saijun, et al.
Publicado: (2022)

An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
por: Lee, S A, et al.
Publicado: (2005)

Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status
por: Meijer, Bartolomeus J., et al.
Publicado: (2018)

Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic
por: Posadzy-Malaczynska, Anna, et al.
Publicado: (2014)

Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB
por: Cui, Yunxia, et al.
Publicado: (2021)

Efficacy of Low-Dose Estrogen–Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis
por: Iwata, Masaru, et al.
Publicado: (2022)

Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma
por: Newtson, A.M., et al.
Publicado: (2017)

The Progestin Receptor Interactome in the Female Mouse Hypothalamus: Interactions with Synaptic Proteins Are Isoform Specific and Ligand Dependent
por: Acharya, Kalpana D., et al.
Publicado: (2017)

Postmenopausal estrogen and progestin effects on the serum proteome
por: Pitteri, Sharon J, et al.
Publicado: (2009)

Relapse of neuromyelitis optica associated with oral progestin
por: Li, Li-Min, et al.
Publicado: (2018)

The Impact of Progestin-only Contraception on Adolescents with Macromastia
por: Nuzzi, Laura C., et al.
Publicado: (2021)

Understanding Progestins: From Basics to Clinical Applicability
por: García-Sáenz, Manuel, et al.
Publicado: (2023)

Effects of Progestin on Modulation of the Expression of Biomarkers in Endometriosis
por: Matasariu, Daniela Roxana, et al.
Publicado: (2023)

Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone
por: Römer, Thomas, et al.
Publicado: (2021)

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
por: Ørbo, Anne, et al.
Publicado: (2016)

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
por: Ørbo, Anne, et al.
Publicado: (2016)

Identification and Validation of MSX1 as a Key Candidate for Progestin Resistance in Endometrial Cancer
por: Yang, Linlin, et al.
Publicado: (2020)

Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells
por: Willibald, Marina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k9dcs4tg3edmjkfrorhfgd3f0c